Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...

Ac-SSO110 has now received FDA orphan drug designation and investigational new drug application clearance for the treatment ...

Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

Discover how AI-powered DeepMerkel improves survival predictions for Merkel cell carcinoma, offering personalized treatment insights for better outcomes.

HURA READ THE FULL HURA RESEARCH REPORT We are initiating coverage of TuHURA Biosciences, Inc. (NASDAQ:HURA) with a valuation ...

In what is being called a major leap forward for cancer care, researchers have developed an artificial intelligence (AI) ...

Ariceum Therapeutics is a private, clinical stage radiopharmaceutical company focused on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers.

The following is a summary of “Skin cancer risk in over 200.000 patients with haematologic malignancies in 30 years; a ...